Tumor Diagnostik und Therapie
SJR0.124
DE
DEJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.124 | Q4 | 8.3% | |
| 2024 | — | — | 0.102 | Q4 | 2.8% | |
| 2023 | — | — | 0.101 | Q4 | 7.2% | |
| 2022 | — | — | 0.101 | Q4 | 10.7% | |
| 2021 | — | — | 0.106 | Q4 | 18.2% | |
| 2020 | — | — | 0.106 | Q4 | 2.3% | |
| 2019 | — | — | 0.100 | Q4 | 0.8% | |
| 2018 | — | — | 0.100 | Q4 | 0.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
1439-1279
ISSN
0722-219X
country
DEcoverage
1983-2025